awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55009872-7314E179-FBEE-4097-A38E-321A84F851B7
Q55009872-7314E179-FBEE-4097-A38E-321A84F851B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55009872-7314E179-FBEE-4097-A38E-321A84F851B7
T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report.
P2860
Q55009872-7314E179-FBEE-4097-A38E-321A84F851B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55009872-7314E179-FBEE-4097-A38E-321A84F851B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a9a2521cca56cb0b8f4995b21c29e34f41769593
P2860
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.